InsiderTrades.com logo

IDYA Insider Trading

Insider Ownership Percentage: 2.50%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

IDEAYA Biosciences Insider Trading History Chart

This chart shows the insider buying and selling history at IDEAYA Biosciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

IDEAYA Biosciences Share Price & Price History

Current Price: $32.07
Price Change: ▼ Price Decrease of -0.04 (-0.12%)
As of 02/24/2026 05:00 PM ET

This chart shows the closing price history over time for IDYA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

IDEAYA Biosciences Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/29/2024Michael Anthony WhiteinsiderSell28,500$36.24$1,032,840.00View SEC Filing Icon  
5/16/2024Yujiro S. HataCEOSell34,433$41.81$1,439,643.73677,887View SEC Filing Icon  
5/14/2024Yujiro S. HataCEOSell56,711$41.61$2,359,744.71677,887View SEC Filing Icon  
2/9/2024Andres Ruiz BrisenoInsiderSell2,000$46.02$92,040.0024,531View SEC Filing Icon  
2/9/2024Yujiro S. HataCEOSell23,557$45.54$1,072,785.78677,887View SEC Filing Icon  
1/22/2024Andres Ruiz BrisenoInsiderSell2,000$42.03$84,060.0026,531View SEC Filing Icon  
1/16/2024Yujiro S. HataCEOSell62,739$40.17$2,520,225.63677,887View SEC Filing Icon  
1/12/2024Andres Ruiz BrisenoInsiderSell2,000$38.01$76,020.0028,531View SEC Filing Icon  
1/12/2024Yujiro S. HataCEOSell12,261$40.04$490,930.44677,887View SEC Filing Icon  
12/15/2023Yujiro S. HataCEOSell75,000$35.03$2,627,250.00677,887View SEC Filing Icon  
12/14/2023Andres Ruiz BrisenoInsiderSell2,000$34.00$68,000.0030,531View SEC Filing Icon  
11/3/2023Jason ThroneinsiderSell5,163$30.09$155,354.67View SEC Filing Icon  
9/12/2023Jason ThroneinsiderSell1,000$30.00$30,000.00View SEC Filing Icon  
9/5/2023Jason ThroneinsiderSell1,737$30.03$52,162.11View SEC Filing Icon  
9/1/2023Jason ThroneinsiderSell2,100$30.03$63,063.0032,531View SEC Filing Icon  
8/29/2023Paul A. StoneCFOSell5,000$28.87$144,350.009,303View SEC Filing Icon  
8/21/2023Paul A. StoneCFOSell978$26.40$25,819.2014,303View SEC Filing Icon  
8/18/2023Paul A. StoneCFOSell3,822$26.38$100,824.3615,281View SEC Filing Icon  
8/16/2023Paul A. StoneCFOSell200$26.43$5,286.0019,103View SEC Filing Icon  
8/9/2023Jason ThroneinsiderSell5,000$25.09$125,450.00View SEC Filing Icon  
8/9/2023Paul A. StoneCFOSell2,500$25.05$62,625.0019,303View SEC Filing Icon  
7/10/2023Jason ThroneinsiderSell9,485$23.00$218,155.00View SEC Filing Icon  
5/31/2023Jason ThroneinsiderSell432$23.00$9,936.00View SEC Filing Icon  
5/22/2023Jason ThroneinsiderSell500$23.00$11,500.00View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for IDEAYA Biosciences (NASDAQ:IDYA)

98.29% of IDEAYA Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at IDYA by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

IDEAYA Biosciences Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/19/2026Invesco Ltd.238,314$8.24M0.0%+91.9%0.272%Search for SEC Filing on Google Icon
2/18/2026XTX Topco Ltd66,175$2.29M0.1%N/A0.075%Search for SEC Filing on Google Icon
2/18/2026Virtus Investment Advisers LLC7,819$0.27M0.1%+53.1%0.009%Search for SEC Filing on Google Icon
2/18/2026Wellington Management Group LLP34,672$1.20M0.0%-5.7%0.040%Search for SEC Filing on Google Icon
2/18/2026Susquehanna Portfolio Strategies LLC202,434$7M0.1%+24.0%0.231%Search for SEC Filing on Google Icon
2/18/2026Tang Capital Management LLC450,000$15.56M0.8%+12.5%0.513%Search for SEC Filing on Google Icon
2/18/2026Tudor Investment Corp ET AL47,938$1.66M0.0%+27.5%0.055%Search for SEC Filing on Google Icon
2/18/2026Odyssean LLC21,129$0.73M0.5%N/A0.024%Search for SEC Filing on Google Icon
2/18/2026Millennium Management LLC208,548$7.21M0.0%+51.6%0.238%Search for SEC Filing on Google Icon
2/18/2026Man Group plc23,826$0.82M0.0%+74.7%0.027%Search for SEC Filing on Google Icon
2/18/2026Janus Henderson Group PLC7,186,456$248.34M0.1%+11.8%8.197%Search for SEC Filing on Google Icon
2/18/2026Engineers Gate Manager LP29,951$1.04M0.0%N/A0.034%Search for SEC Filing on Google Icon
2/18/2026Cinctive Capital Management LP45,965$1.59M0.1%-8.0%0.052%Search for SEC Filing on Google Icon
2/18/2026Balyasny Asset Management L.P.596,483$20.62M0.0%+56.8%0.680%Search for SEC Filing on Google Icon
2/18/2026Baker BROS. Advisors LP3,618,826$125.10M0.7%+10.5%4.128%Search for SEC Filing on Google Icon
2/18/2026Boothbay Fund Management LLC60,258$2.08M0.0%-19.4%0.069%Search for SEC Filing on Google Icon
2/17/2026Guggenheim Capital LLC6,861$0.24M0.0%-77.7%0.008%Search for SEC Filing on Google Icon
2/17/2026AQR Capital Management LLC68,177$2.36M0.0%+206.7%0.078%Search for SEC Filing on Google Icon
2/17/2026Cetera Investment Advisers24,623$0.85M0.0%+17.8%0.028%Search for SEC Filing on Google Icon
2/17/2026Jain Global LLC21,041$0.73M0.0%+78.9%0.024%Search for SEC Filing on Google Icon
2/17/2026Quantedge Capital Pte Ltd36,700$1.27M0.6%N/A0.042%Search for SEC Filing on Google Icon
2/17/2026Iron Triangle Partners LP467,484$16.16M1.8%+73.1%0.533%Search for SEC Filing on Google Icon
2/17/2026Price T Rowe Associates Inc. MD1,449,145$50.10M0.0%+30.6%1.653%Search for SEC Filing on Google Icon
2/17/2026Osaic Holdings Inc.5,891$0.20M0.0%-37.9%0.007%Search for SEC Filing on Google Icon
2/17/2026Adage Capital Partners GP L.L.C.2,800,000$96.80M0.1%-3.5%3.194%Search for SEC Filing on Google Icon
2/17/2026California State Teachers Retirement System75,945$2.63M0.0%+1.8%0.087%Search for SEC Filing on Google Icon
2/17/2026Russell Investments Group Ltd.9,683$0.34M0.0%+5.2%0.011%Search for SEC Filing on Google Icon
2/17/2026State of Wisconsin Investment Board43,096$1.49M0.0%-7.8%0.049%Search for SEC Filing on Google Icon
2/17/2026ExodusPoint Capital Management LP22,308$0.77M0.0%-59.7%0.025%Search for SEC Filing on Google Icon
2/17/2026Royal Bank of Canada165,323$5.72M0.0%-59.6%0.189%Search for SEC Filing on Google Icon
2/17/2026Graham Capital Management L.P.5,841$0.20M0.0%-60.3%0.007%Search for SEC Filing on Google Icon
2/16/2026Sofinnova Investments Inc.885,121$30.60M1.2%-4.1%1.010%Search for SEC Filing on Google Icon
2/16/2026MML Investors Services LLC83,939$2.90M0.0%+3.2%0.096%Search for SEC Filing on Google Icon
2/16/2026Mariner LLC10,772$0.37M0.0%+12.7%0.012%Search for SEC Filing on Google Icon
2/16/2026Nicholas Investment Partners LP192,413$6.65M0.5%N/A0.219%Search for SEC Filing on Google Icon
2/16/2026First Turn Management LLC723,653$25.02M2.9%N/A0.825%Search for SEC Filing on Google Icon
2/16/2026Eventide Asset Management LLC284,069$9.82M0.2%-54.6%0.324%Search for SEC Filing on Google Icon
2/16/2026Barclays PLC235,872$8.15M0.0%-5.8%0.269%Search for SEC Filing on Google Icon
2/13/2026The Manufacturers Life Insurance Company 69,909$2.42M0.0%+5.1%0.080%Search for SEC Filing on Google Icon
2/13/2026CANADA LIFE ASSURANCE Co7,636$0.26M0.0%-56.2%0.009%Search for SEC Filing on Google Icon
2/13/2026Walleye Capital LLC42,976$1.49M0.0%-46.9%0.049%Search for SEC Filing on Google Icon
2/13/2026Stifel Financial Corp27,339$0.95M0.0%-14.1%0.031%Search for SEC Filing on Google Icon
2/13/2026Bridgefront Capital LLC36,205$1.25M0.3%N/A0.041%Search for SEC Filing on Google Icon
2/13/2026Schroder Investment Management Group171,278$5.91M0.0%-16.8%0.195%Search for SEC Filing on Google Icon
2/13/2026Rafferty Asset Management LLC126,362$4.37M0.0%+35.7%0.144%Search for SEC Filing on Google Icon
2/13/2026First Trust Advisors LP44,079$1.52M0.0%N/A0.050%Search for SEC Filing on Google Icon
2/13/2026Alyeska Investment Group L.P.192,308$6.65M0.0%N/A0.219%Search for SEC Filing on Google Icon
2/13/2026Charles Schwab Investment Management Inc.714,633$24.71M0.0%-0.1%0.815%Search for SEC Filing on Google Icon
2/13/2026Police & Firemen s Retirement System of New Jersey21,276$0.74M0.0%-5.0%0.024%Search for SEC Filing on Google Icon
2/13/2026State Street Corp4,134,641$142.94M0.0%+27.6%4.716%Search for SEC Filing on Google Icon
2/13/2026UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC174,124$6.02M0.0%-13.6%0.199%Search for SEC Filing on Google Icon
2/13/2026Wells Fargo & Company MN256,144$8.86M0.0%+5.4%0.292%Search for SEC Filing on Google Icon
2/13/2026Platinum Investment Management Ltd.120,604$4.17M1.0%-27.7%0.138%Search for SEC Filing on Google Icon
2/13/2026Rhenman & Partners Asset Management AB250,000$8.64M0.8%N/A0.285%Search for SEC Filing on Google Icon
2/12/2026Orion Porfolio Solutions LLC58,394$2.02M0.0%+7.3%0.067%Search for SEC Filing on Google Icon
2/12/2026MetLife Investment Management LLC45,813$1.58M0.0%-5.6%0.052%Search for SEC Filing on Google Icon
2/12/2026GSK plc1,333,333$46.09M5.8%N/A1.521%Search for SEC Filing on Google Icon
2/12/2026Dimensional Fund Advisors LP938,857$32.46M0.0%+88.9%1.071%Search for SEC Filing on Google Icon
2/12/2026Federated Hermes Inc.3,395,771$117.39M0.2%-26.6%3.874%Search for SEC Filing on Google Icon
2/12/2026Ensign Peak Advisors Inc979,063$33.85M0.1%+30.0%1.117%Search for SEC Filing on Google Icon
2/12/2026New York State Common Retirement Fund508,347$17.57M0.0%+4.0%0.580%Search for SEC Filing on Google Icon
2/12/2026Alps Advisors Inc.71,789$2.48M0.0%+70.3%0.082%Search for SEC Filing on Google Icon
2/12/2026Swiss National Bank155,600$5.38M0.0%+1.8%0.177%Search for SEC Filing on Google Icon
2/12/2026Great Lakes Advisors LLC149,993$5.19M0.0%N/A0.171%Search for SEC Filing on Google Icon
2/12/2026Nuveen LLC374,007$12.93M0.0%+79.2%0.427%Search for SEC Filing on Google Icon
2/12/2026Xponance LLC6,315$0.22M0.0%N/A0.007%Search for SEC Filing on Google Icon
2/11/2026Deutsche Bank AG368,481$12.74M0.0%-9.2%0.420%Search for SEC Filing on Google Icon
2/11/2026Franklin Resources Inc.240,209$8.30M0.0%+2.0%0.274%Search for SEC Filing on Google Icon
2/11/2026JPMorgan Chase & Co.299,888$10.37M0.0%+72.1%0.342%Search for SEC Filing on Google Icon
2/11/2026Fiera Capital Corp2,437,262$84.26M0.3%+32.6%2.780%Search for SEC Filing on Google Icon
2/11/2026Capital Research Global Investors5,279,675$182.52M0.0%-19.4%6.022%Search for SEC Filing on Google Icon
2/11/2026BIT Capital GmbH16,900$0.58M0.0%+459.8%0.019%Search for SEC Filing on Google Icon
2/11/2026Parallel Advisors LLC3,847$0.13M0.0%+23.4%0.004%Search for SEC Filing on Google Icon
2/11/2026Daiwa Securities Group Inc.2,258$78K0.0%-20.5%0.003%Search for SEC Filing on Google Icon
2/10/2026TD Asset Management Inc46,040$1.59M0.0%+74.1%0.053%Search for SEC Filing on Google Icon
2/10/2026Lido Advisors LLC55,465$1.91M0.0%N/A0.063%Search for SEC Filing on Google Icon
2/10/2026Goldman Sachs Group Inc.1,770,866$61.22M0.0%+43.6%2.020%Search for SEC Filing on Google Icon
2/10/2026Norges Bank30,589$1.06M0.0%N/A0.035%Search for SEC Filing on Google Icon
2/10/2026Intech Investment Management LLC33,506$1.16M0.0%+11.1%0.038%Search for SEC Filing on Google Icon
2/9/2026Geode Capital Management LLC2,073,583$71.70M0.0%-3.6%2.365%Search for SEC Filing on Google Icon
2/9/2026Knights of Columbus Asset Advisors LLC33,199$1.15M0.1%-3.3%0.038%Search for SEC Filing on Google Icon
2/9/2026AlphaQuest LLC38,767$1.34M0.1%-5.5%0.044%Search for SEC Filing on Google Icon
2/9/2026Fisher Asset Management LLC889,633$30.76M0.0%+3.2%1.015%Search for SEC Filing on Google Icon
2/6/2026Legato Capital Management LLC23,900$0.83M0.1%N/A0.027%Search for SEC Filing on Google Icon
2/6/2026Nano Cap New Millennium Growth Fund L P21,500$0.74M0.6%N/A0.025%Search for SEC Filing on Google Icon
2/6/2026Global Retirement Partners LLC1,760$61K0.0%N/A0.002%Search for SEC Filing on Google Icon
2/6/2026Atle Fund Management AB97,438$3.37M1.1%N/A0.111%Search for SEC Filing on Google Icon
2/6/2026Fideuram Intesa Sanpaolo Private Banking S.P.A.113,451$3.92M0.1%N/A0.129%Search for SEC Filing on Google Icon
2/6/2026PNC Financial Services Group Inc.3,504$0.12M0.0%-9.7%0.004%Search for SEC Filing on Google Icon
2/6/2026Handelsbanken Fonder AB30,900$1.07M0.0%-16.5%0.035%Search for SEC Filing on Google Icon
2/6/2026Profund Advisors LLC47,115$1.63M0.0%+127.7%0.054%Search for SEC Filing on Google Icon
2/6/2026ProShare Advisors LLC18,565$0.64M0.0%+10.2%0.021%Search for SEC Filing on Google Icon
2/5/2026AlphaCore Capital LLC6,757$0.23M0.0%N/A0.008%Search for SEC Filing on Google Icon
2/5/2026ANTIPODES PARTNERS Ltd1,150$40K0.0%+49.4%0.001%Search for SEC Filing on Google Icon
2/5/2026Baader Bank Aktiengesellschaft13,000$0.45M0.0%N/A0.015%Search for SEC Filing on Google Icon
2/3/2026Wesbanco Bank Inc.39,700$1.37M0.0%+87.3%0.045%Search for SEC Filing on Google Icon
2/3/2026Mitsubishi UFJ Asset Management Co. Ltd.5,191$0.18M0.0%-41.0%0.006%Search for SEC Filing on Google Icon
2/2/2026Strs Ohio25,100$0.87M0.0%N/A0.029%Search for SEC Filing on Google Icon
2/2/2026Oppenheimer Asset Management Inc.15,729$0.54M0.0%-3.5%0.018%Search for SEC Filing on Google Icon
1/30/2026State of New Jersey Common Pension Fund D26,923$0.93M0.0%-68.8%0.031%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
IDEAYA Biosciences logo
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, discovers and develops targeted therapeutics for patient populations selected using molecular diagnostics in the United States. The company's products in development include IDE196, a protein kinase C inhibitor that is in Phase 2/3 clinical trials for genetically defined cancers having GNAQ or GNA11 gene mutations; IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase 1/2 clinical trials for patients with solid tumors having methylthioadenosine phosphorylase gene deletions, such as non-small cell lung, bladder, gastric, and esophageal cancers; IDE161, a poly ADP-ribose glycohydrolase inhibitor that is in Phase 1 clinical trial to treat tumors with homologous recombination deficiency (HRD), and other genetic or molecular signatures; GSK101, a Pol Theta Helicase inhibitor that is in Phase 1 clinical trial for the treatment of tumors with BRCA or other homologous recombination, and HRD mutations; and Werner Helicase inhibitors for tumors with high microsatellite instability. It offers preclinical research programs focused on pharmacological inhibition; DECIPHER dual CRISPR library for synthetic lethality target and biomarker discovery; and INQUIRE chemical library and HARMONY machine-learning engines to enhance its drug discovery platform. The company has strategic alliances with GlaxoSmithKline, Pfizer Inc., Novartis International Pharmaceuticals Ltd., Amgen Inc., Gilead Sciences, Inc., Cancer Research UK, and the University of Manchester. IDEAYA Biosciences, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.
Read More on IDEAYA Biosciences

Today's Range

Now: $32.07
Low: $31.55
High: $32.88

50 Day Range

MA: $34.17
Low: $30.27
High: $37.86

52 Week Range

Now: $32.07
Low: $13.45
High: $39.28

Volume

730,415 shs

Average Volume

904,434 shs

Market Capitalization

$2.82 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.1

Who are the company insiders with the largest holdings of IDEAYA Biosciences?

IDEAYA Biosciences' top insider investors include:
  1. Yujiro S Hata (CEO)
  2. Michael Anthony White (Insider)
Learn More about top insider investors at IDEAYA Biosciences.

Who are the major institutional investors of IDEAYA Biosciences?

IDEAYA Biosciences' top institutional shareholders include:
  1. Janus Henderson Group PLC — 8.20%
  2. Capital Research Global Investors — 6.02%
  3. Vanguard Group Inc. — 5.73%
  4. State Street Corp — 4.72%
  5. Baker BROS. Advisors LP — 4.13%
  6. Federated Hermes Inc. — 3.87%
Learn More about top institutional investors of IDEAYA Biosciences stock.

Which institutional investors are selling IDEAYA Biosciences stock?

Within the last quarter, IDYA stock was sold by these institutional investors:
  1. Capital Research Global Investors
  2. Federated Hermes Inc.
  3. Eventide Asset Management LLC
  4. Pictet Asset Management Holding SA
  5. Royal Bank of Canada
  6. Adage Capital Partners GP L.L.C.
  7. Geode Capital Management LLC
  8. State of New Jersey Common Pension Fund D

Which institutional investors are buying IDEAYA Biosciences stock?

In the previous quarter, IDYA stock was bought by institutional investors including:
  1. GSK plc
  2. State Street Corp
  3. Janus Henderson Group PLC
  4. First Turn Management LLC
  5. Fiera Capital Corp
  6. Goldman Sachs Group Inc.
  7. Dimensional Fund Advisors LP
  8. Baker BROS. Advisors LP